| Business Summary | | Minntech
Corporation
is
engaged
in
the
development,
manufacture
and
marketing
of
medical
supplies
and
devices,
sterilants
and
filtration
and
separation
products.
The
Company's
products
are
used
primarily
in
kidney
dialysis
and
in
open-heart
surgery.
The
trade
name
of
Minntech
Renal
Systems
is
used
for
products
sold
in
the
dialysis
market,
and
the
trade
name
of
Minntech
Fibercor
is
used
for
filtration
and
separation
products
marketed
to
the
pharmaceutical,
medical,
semiconductor
and
biotechnology
industries.
The
Company
has
core
technologies
in
electronics,
fibers,
plastics
and
chemical
solutions,
all
of
which
were
internally
developed.
The
Company
has
three
interrelated
product
segments:
Dialysis
Products,
Cardiosurgery
Products
and
Developing
Businesses
(including
filtration
and
separation
and
endoscope
reprocessing
products). | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | MNTX
develops,
manufactures
and
markets
medical
devices
and
supplies,
sterilants
and
water
filtration
products
used
primarily
in
kidney
dialysis
and
in
open-heart
surgery.
For
the
three
months
ended
6/30/01,
revenues
increased
13%
to
$20
million.
Net
income
before
accounting
change
totaled
$1.2
million
vs.
a
loss
of
$61
thousand.
Revenues
reflect
strong
sales
volume
across
all
business
segments.
Net
income
also
reflects
a
higher
gross
margin
due
to
cost
efficiencies. | More
from
Market Guide: Significant
Developments |
| | | | FY2001 Pay | |
| William Hope, 67 Chairman | $197K | R. James Danehy, 56 Pres,
CEO, Director | 120K | Jules Fisher, 47 CFO,
VP | 172K | Barbara Wrigley, 49 Exec.
VP, Sec. | 233K | Paul Helms, 55 Sr.
VP--Operations | 216K | Dollar amounts are as of 31-Mar-2001 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|